SUCCESS STORIES

"The Right Touch of Guidance, Leadership and Counsel" I sought the services of J.W. Webb to help me with an important management team meeting in which I wanted our team to assess our past year’s performance and then establish a clear strategic framework for our aspirations in the coming year.

Because of my previous experience with Mark Womack, it was a “no-brainer” that they were the right choice to assist me in the design and execution of such an important leadership undertaking.

Mark closely partnered with me to provide just the right touch of guidance, leadership and counsel. Together, we developed a crystal-clear, highly ambitious set of meeting objectives and agenda. We also established leadership and behavioral standards for how my team would operate during the off-site, both individually and collectively.

During the off-site sessions, we were able to exceed my high aspirations for how much we would achieve and for how we would work together. While I certainly give a lot of credit to my very talented team members, our performance was significantly enhanced due to Mark's guidance and commitment to helping us operate at the highest possible level. Mark is relentless about staying the course and holding everyone accountable to agreed-to standards, which enabled us to achieve our lofty ambitions.

As a result, we developed a clear set of business imperatives that have proven to be meaningful guideposts for the leadership team over the course of the business year. We not only developed a solid strategy and plan for the coming year, we also visibly became a stronger and more effective team through the process. My organization continues to greatly benefit from the tangible and intangible results of this off-site.

– Paul Heiden, Ph.D.
   Sr. Vice President
   Bayer Biological Products


Paul Heiden is a senior executive of Bayer, a multinational Fortune 500 company specializing in Healthcare, Polymers, Chemicals and Crop Science. Dr. Heiden began his career with Tropon, a former pharmaceutical subsidiary of Bayer AG in 1987, where he eventually headed the Quality Assurance function. In 1992, he joined Bayer's Consumer Healthcare U.S. operations as the Head of Quality Assurance and member of the Executive Management Team. In 1996 he joined Bayer's Pharmaceutical Division at it's Leverkusen, Germany headquarters as the Global Compliance Officer.

Later as the Head of Global Quality Assurance and a member of the Pharma Management Committee, he was responsible for the analytical development of Bayer's drug development pipeline and all Quality Assurance Operations worldwide. In 1999, he left this position and relocated again to the U.S. on an assignment from Bayer's board to serve as a member of the Leadership Committee of the Biological Products Division, specializing in protein drugs originated from plasma fractionation and biotechnology. In 2000, he was made responsible for Technical Operations of the Active Ingredients Manufacturing Plant of Bayer's Pharma Division in Wuppertal, Germany.

After moving to the U.S. in 2001, he has served as the Vice President, Technical Operations for Biological Product's Berkeley, California facility. Bayer's biotechnology operations at this site produce protein therapeutics for the treatment of life-threatening diseases, such as KogenateTM, a recombinant FVIII product for the treatment of hemophilia. In his current position, Paul is the Berkeley Site Manager and Senior Vice President of Bayer Biologicals. He received his Ph.D. degree of Pharmaceutical Chemistry from the University of Bonn, Germany in 1986 and received several academic awards and distinctions for his work during his academic career.